Combination Therapy in Cancers With Mutations in DNA Repair Genes

Clinical trial NCT05694715 · RECRUITING

Trial details

NCT number: NCT05694715
Sponsor: University of California, San Francisco
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Solid Tumor BRCA1 Mutation BRCA2 Mutation ATM Gene Mutation PALB2 Gene Mutation

Start date: 2023-05-23
Primary completion: 2028-01-31
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.